Latest filings (excl ownership)
DEF 14A
Definitive proxy
29 Apr 24
8-K
Regulation FD Disclosure
23 Apr 24
8-K
CervoMed Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
5 Apr 24
8-K
Regulation FD Disclosure
4 Apr 24
10-K
2023 FY
Annual report
29 Mar 24
8-K
CervoMed Announces Up to $149.4 Million Private Placement Financing Joined by Leading Healthcare Investors
28 Mar 24
8-K
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
18 Mar 24
8-K
Regulation FD Disclosure
5 Mar 24
8-K
Entry into a Material Definitive Agreement
28 Feb 24
8-K
CervoMed Announces Appointment of Industry Leader Joshua Boger, Ph.D., as Chair of the Board
7 Feb 24
8-K
Entry into a Material Definitive Agreement
2 Feb 24
8-K
CervoMed to Participate in the Emerging Growth Conference 66
5 Jan 24
8-K
Regulation FD Disclosure
4 Jan 24
8-K
Regulation FD Disclosure
21 Dec 23
8-K
Entry into a Material Definitive Agreement
17 Nov 23
8-K
CervoMed Reports Third Quarter 2023 Financial Results and Business Highlights
13 Nov 23
10-Q
2023 Q3
Quarterly report
13 Nov 23
8-K
Departure of Directors or Certain Officers
8 Nov 23
8-K
Departure of Directors or Certain Officers
31 Oct 23
8-K
Regulation FD Disclosure
25 Oct 23
8-K
Regulation FD Disclosure
3 Oct 23
S-8
Registration of securities for employees
29 Sep 23
8-K/A
Completion of Acquisition or Disposition of Assets
29 Sep 23
8-K
Other Events
6 Sep 23
8-K
Diffusion Pharmaceuticals Stockholders Approve Merger with EIP Pharma
17 Aug 23
425
Business combination disclosure
14 Aug 23
8-K
EIP Pharma Announces First Patient Dosed in RewinD-LB Phase 2b Clinical Trial Evaluating Neflamapimod in Dementia with Lewy Bodies
14 Aug 23
425
Business combination disclosure
9 Aug 23
8-K
Other Events
9 Aug 23
10-Q
2023 Q2
Quarterly report
8 Aug 23
425
Business combination disclosure
3 Aug 23
8-K
Other Events
3 Aug 23
425
Business combination disclosure
3 Aug 23
8-K
EIP Pharma to Present at Canaccord Genuity 43rd Annual Growth Conference
3 Aug 23
425
Business combination disclosure
31 Jul 23
8-K
Entry into a Material Definitive Agreement
31 Jul 23
EFFECT
Notice of effectiveness
14 Jul 23
424B3
Prospectus supplement
13 Jul 23
SEC STAFF
SEC staff action: Order
13 Jul 23
CORRESP
Correspondence with SEC
12 Jul 23
Latest ownership filings
SC 13G
RA CAPITAL MANAGEMENT, L.P.
11 Apr 24
SC 13G/A
AI EIPP Holdings LLC
6 Mar 24
SC 13D/A
BOGER JOSHUA S
28 Feb 24
4
JOSHUA S BOGER
28 Feb 24
SC 13G/A
AI EIPP Holdings LLC
14 Feb 24
4
JOSHUA S BOGER
13 Feb 24
SC 13D
BOGER JOSHUA S
9 Feb 24
3
JOSHUA S BOGER
9 Feb 24
4
JOHN J ALAM
26 Jan 24
4
Kelly Blackburn
26 Jan 24
4
JOHN WILLIAM TANNER
26 Jan 24
4
WILLIAM ROBERT ELDER
26 Jan 24
4
Sylvie Gregoire
26 Jan 24
4
Robert Joseph Jr. Cobuzzi
26 Jan 24
4
JOHN WILLIAM TANNER
22 Nov 23
4
Sylvie Gregoire
9 Nov 23
4
JOHN J ALAM
9 Nov 23
4
Robert Joseph Jr. Cobuzzi
15 Sep 23
4
JOHN WILLIAM TANNER
15 Sep 23
4
JOHN J ALAM
15 Sep 23
4
FRANK ZAVRL
15 Sep 23
4
Marwan Sabbagh
15 Sep 23
4
Jeffrey V. Poulton
15 Sep 23
4
Jane H Hollingsworth
15 Sep 23
4
Sylvie Gregoire
15 Sep 23
4
WILLIAM ROBERT ELDER
15 Sep 23
4
JILL DAVIDSON
15 Sep 23
4
Kelly Blackburn
15 Sep 23
4
Jane H Hollingsworth
6 Sep 23
SC 13G
AI EIPP Holdings LLC
28 Aug 23
SC 13D
ZAVRL FRANK
28 Aug 23
SC 13D
ALAM JOHN J
28 Aug 23
3
FRANK ZAVRL
25 Aug 23
3
Marwan Sabbagh
24 Aug 23
3
Kelly Blackburn
23 Aug 23
3
JOHN J ALAM
23 Aug 23
3
Sylvie Gregoire
23 Aug 23
3
Jeffrey V. Poulton
23 Aug 23
3
JOHN WILLIAM TANNER
23 Aug 23
3
JILL DAVIDSON
11 Aug 23